Debika Bhattacharya

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial
    Prudence Ive
    Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 8:e74900. 2013
  2. pmc Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach
    Debika Bhattacharya
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    J Virol Methods 190:34-40. 2013
  3. pmc Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance
    D Bhattacharya
    Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J STD AIDS 19:780-1. 2008
  4. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
  5. pmc Review of hepatitis B therapeutics
    Debika Bhattacharya
    David Geffen School of Medicine at the University of California, Los Angeles, USA
    Clin Infect Dis 51:1201-8. 2010
  6. doi request reprint Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
    Romney M Humphries
    UCLA David Geffen School of Medicine, Department of Pathology and Laboratory Medicine, Los Angeles, CA, USA
    J Med Microbiol 59:1383-6. 2010
  7. pmc Impact of prison status on HIV-related risk behaviors
    Angela L Hudson
    School of Nursing, University of California Los Angeles, CA 90095, USA
    AIDS Behav 15:340-6. 2011
  8. ncbi request reprint Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies
    Debika Bhattacharya
    Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Clin Gastroenterol Hepatol 4:288-92. 2006
  9. pmc Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California
    Debika Bhattacharya
    Stanford University, Stanford, California, USA
    J Clin Microbiol 45:1798-803. 2007

Detail Information

Publications9

  1. pmc Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial
    Prudence Ive
    Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
    PLoS ONE 8:e74900. 2013
    ..In this study, we analysed data from the CIPRA-SA 'Safeguard the household study' in order to assess baseline HBV characteristics in HIV/HBV co-infection participants prior to antiretroviral therapy (ART) initiation...
  2. pmc Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach
    Debika Bhattacharya
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    J Virol Methods 190:34-40. 2013
    ....
  3. pmc Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance
    D Bhattacharya
    Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J STD AIDS 19:780-1. 2008
    ..In HIV/HBV co-infection, measurement of HBV DNA and HBV resistance mutations may identify HBV virological failure before biochemical changes and should be routinely used in the management of HIV/HBV co-infection...
  4. pmc Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis
    Debika Bhattacharya
    University of California, Los Angeles, CA, USA
    J Acquir Immune Defic Syndr 55:170-5. 2010
    ..In HIV/ hepatitis C virus (HCV) coinfection, adverse events (AEs) during HCV therapy account for 12%-39% of treatment discontinuations. It is unknown whether sex influences complications...
  5. pmc Review of hepatitis B therapeutics
    Debika Bhattacharya
    David Geffen School of Medicine at the University of California, Los Angeles, USA
    Clin Infect Dis 51:1201-8. 2010
    ..We will also offer guidelines for the use of available anti-HBV agents and review the emerging challenges in hepatitis B management, including HBV drug resistance, its management, and the potential role of combination therapy...
  6. doi request reprint Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin
    Romney M Humphries
    UCLA David Geffen School of Medicine, Department of Pathology and Laboratory Medicine, Los Angeles, CA, USA
    J Med Microbiol 59:1383-6. 2010
    ..Despite a poor prognosis, the patient recovered, but remains colonized with the pan-resistant isolate...
  7. pmc Impact of prison status on HIV-related risk behaviors
    Angela L Hudson
    School of Nursing, University of California Los Angeles, CA 90095, USA
    AIDS Behav 15:340-6. 2011
    ..As risk for HCV and HIV co-infection continues among homeless ex-offenders, HIV/HCV prevention efforts are needed for this population...
  8. ncbi request reprint Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies
    Debika Bhattacharya
    Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
    Clin Gastroenterol Hepatol 4:288-92. 2006
  9. pmc Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in Northern California
    Debika Bhattacharya
    Stanford University, Stanford, California, USA
    J Clin Microbiol 45:1798-803. 2007
    ..Clinicians should assess for nosocomial and community risk factors, realizing that different populations with CO-MRSA SSTI may require separate antimicrobial strategies...